| n/N | % | RR | 95% CI | Adjusted RR | 95% CI |
---|---|---|---|---|---|---|
Gender | ||||||
 Female | 75/258 | 29.1 | Ref | Ref | Ref | Ref |
 Male | 86/279 | 30.8 | 1.09 | (0.79–1.49) | 1.01 | (0.74–1.41) |
Age, years | ||||||
  < 30 | 31/138 | 22.5 | Ref | Ref | Ref | Ref |
 30–45 | 93/282 | 32.9 | 1.56 | (1.02–2.37) | 1.46 | (0.94–2.25) |
  ≥ 45 | 37/117 | 31.6 | 1.46 | (0.89–2.38) | 1.43 | (0.86–2.37) |
DR-TB classification | ||||||
 RR-TB by Xpert MTB/RIF | 96/237 | 40.5 | 4.36 | (2.60–7.30) | 4.31 | (2.55–7.29) |
 RIF mono-resistant TB | 47/109 | 43.1 | 4.76 | (2.70–8.36) | 4.46 | (2.07–7.95) |
 MDR-TB | 18/191 | 9.4 | Ref | Ref | Ref | Ref |
HIV status at initiation | ||||||
 HIV negative | 14/61 | 22.1 | 0.58 | (0.32–1.05) | 0.75 | (0.47–1.20) |
 HIV positive on ART | 120/351 | 33.4 | Ref | Ref | Ref | Ref |
 HIV positive not on ART | 16/77 | 19.5 | 0.6 | (0.36–1.02) | 0.73 | (0.43–1.25) |
 HIV status unknown | 11/48 | 22.9 | 0.64 | (0.33–1.21) | 0.76 | (0.43–1.24) |
Registration year | ||||||
 2011 | 19/55 | 34.5 | Ref | Ref | Ref | Ref |
 2012 | 33/108 | 30.6 | 0.88 | (0.50–1.56) | 0.88 | (0.49–1.56) |
 2013 | 49/166 | 29.5 | 0.81 | (0.47–1.37) | 0.74 | (0.43–1.28) |
 2014 | 60/211 | 28.4 | 0.84 | (0.50–1.41) | 0.83 | (0.49–1.41) |
Time to treatment initiation | ||||||
 Without delay | 70/186 | 37.6 | Ref | Ref | Ref | Ref |
 Delayed (deferred) | 85/332 | 25.6 | 0.97 | (0.71–1.33) | 0.94 | (0.66–1.33) |